Thinking and memory in lung cancer patients
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This study looks at how lung cancer and its treatments may affect thinking and memory. You will fill out questionnaires on your phone, tablet, or computer at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old
- You have suspected or confirmed lung cancer that can be removed with surgery
- You can use a phone, tablet, or computer to answer online questionnaires
- You can read and understand French
- You do not have a known memory or thinking problem, or a major psychiatric or brain condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to help people with breast or lung cancer who worry about their cancer coming back. You will answer questionnaires about your fears, so the care team can better support you.
This study is testing a simple thinking and memory check for people with lung cancer. The goal is to find out how common cognitive problems are and to help doctors better support patients.
This study tests a digital program to help people who have thinking or memory problems after cancer treatment. You'll use a phone, tablet, or computer to practice skills that may improve your focus and memory.
This study looks at how certain targeted therapy drugs for ALK/ROS1-positive lung cancer may affect thinking, memory, mood, and mental health. It aims to build a special care and research path where patients and researchers work together to understand and manage these side effects.
This trial tests a cognitive rehabilitation program for breast cancer survivors who have ongoing problems with thinking, memory, or concentration after finishing treatment. The goal is to help improve daily mental function.
This trial studies how radiotherapy affects memory and thinking in adults with certain brain or skull-base tumors. It may help doctors understand who is most likely to have thinking changes and how to monitor or support patients.
Hear when a new Localized, Operable Non-small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.